Marc-Alexander Burmeister – President, B. Braun France
Dr Marc-Alexander Burmeister, president of B. Braun in France, shares the exciting changes to come for B. Braun globally and in France, and discusses the shifting environment of healthcare in…
For 175 years, B. Braun has been the trusted partner of healthcare facilities through its range of innovative products and services and safety, suitable for all patient treatment steps.
A family group of German origin, B. Braun specializes in the design, production and marketing of medical and surgical equipment, pharmaceutical products and related services. The Group has over 140 subsidiaries worldwide. In 2015, the Group achieved a turnover of over 6.13 billion euros with a workforce of 56,000 employees in 64 countries.
In France, B. Braun develops, manufactures and markets hospital medical devices, implants, and pharmaceutical products in the areas of surgery, infusion, intensive care and regional anesthesia.
B. Braun also accompanied home patients with chronic diseases in the fields of stoma, continence, wound care and diabetes.In 2014, B. Braun achieved a turnover of over EUR 284 million in France .
Contact
B. Braun
204 Avenue du Maréchal
92100 Boulogne
France
+33 1 41 10 53 00
+33 1 41 10 53 99
www.bbraun.fr
Dr Marc-Alexander Burmeister, president of B. Braun in France, shares the exciting changes to come for B. Braun globally and in France, and discusses the shifting environment of healthcare in…
France is betting big on industrial transformation. With its sweeping EUR 54 billion France 2030 investment plan, the government has laid down a clear ambition: to become a global leader…
As the global population ages and the incidence of vision-related conditions rises, ophthalmology is entering a transformative era. Beyond symptom management, the field is moving towards disease modification through cell…
Serge Picaud, the Executive Director of the Paris Vision Institute outlines a bold vision to transform ophthalmology through cutting-edge research and innovation. From pioneering the first successful optogenetic vision restoration…
Thomas Courbe, Director General for Enterprise at the French Ministry of Economy and Finance, has led France’s industrial transformation since 2019. He oversees, within the EURO 54 billion France 2030…
Julien Ettersperger, appointed in November 2023 as the first internal leader of Medicen, is steering the agency through a strategic transformation to establish Île-de-France as Europe’s leading health innovation hub.…
Professor Bana Jabri, Director of the Institut Imagine, brings a transatlantic perspective to advancing genetic medicine. After 25 years in the US, she now leads efforts in France to harness…
As global powers race to secure health sovereignty and industrial resilience, France stands at a crossroads. With rising regulatory asymmetries, fierce international competition, and mounting fiscal pressure on its pharmaceutical…
France is experiencing its biggest pharmaceutical manufacturing boom in decades, with global giants like Novo Nordisk, Sanofi, and Pfizer committing over EUR 4 billion in new investments since 2023. This…
The biggest recent stories from French healthcare and the life sciences, including Sanofi’s deal to buy immunology biotech Blueprint; the largest from a European pharma this year. Elsewhere Servier is…
At the end of a turbulent and lengthy process, France’s 2025 health budget has finally been approved. This “imperfect” budget resulting from months of debate in a parliament with no…
A new book by two pharma industry experts offers the first truly global perspective on the complexities of market access. Even the most innovative drug is useless if patients…
François Bayrou’s new administration in France, sworn in after the previous, three-month-old government was toppled by a no-confidence vote, brings a new health minister to a post recently characterized by…
See our Cookie Privacy Policy Here
